Gary Choy

Gary Choy is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Co-Founder, Chairman, and CEO of f5 Therapeutics Incorporated since April 2020, focusing on targeted protein degradation for drug discovery. In addition, Gary Choy is the Founder, CEO, and Principal Consultant at T & G Consulting LLC, which aids emerging biotech companies in exploring commercial potentials. Previous roles include Vice President of Marketing at Samumed LLC and Global Marketing Leader for Rheumatology at The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities encompassed strategic market development and product launches. Gary Choy's extensive experience also includes leadership positions in sales and marketing at Idenix Pharmaceuticals, Roche, Abbott, and Pfizer. Academic qualifications include a BS in Marketing and Biology from Rutgers Business School and an MBA in Marketing from Rutgers University - Newark.